Allegra Allergy Tablet, Coated
Product Images NDC 41167-4122

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra Allergy (NDC 41167-4122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ndc 41167-4122-0allegra® Allergyfexofenadine Hci Tablets180 mg/antihistamine24 Hr8 Gelcaps (Allegra Gelcaps 01)

Ndc 41167-4122-0allegra® Allergyfexofenadine Hci Tablets180 mg/antihistamine24 Hr8 Gelcaps (Allegra Gelcaps 01)
This is a description of a non-drowsy allergy relief medication in the form of gelcaps. The product contains 180mg of fexofenadine HCl, an antihistamine, and is designed to alleviate symptoms of indoor and outdoor allergies such as sneezing and runny nose. The packaging includes 8 gelcaps and mentions the absence of coating tablets. However, some of the text appears to be non-readable or gibberish, such as "N'or?!onqwsv" and "ALLEIsG-ngra".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.